Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-01-07 @ 5:48 AM
Study NCT ID:
NCT00334958
Status:
COMPLETED
Last Update Posted:
2021-06-14
First Post:
2006-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures
Sponsor:
Eisai Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
E2080-A001-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None